CA2880299A1 - Process for the synthesis of substituted urea compounds - Google Patents

Process for the synthesis of substituted urea compounds Download PDF

Info

Publication number
CA2880299A1
CA2880299A1 CA2880299A CA2880299A CA2880299A1 CA 2880299 A1 CA2880299 A1 CA 2880299A1 CA 2880299 A CA2880299 A CA 2880299A CA 2880299 A CA2880299 A CA 2880299A CA 2880299 A1 CA2880299 A1 CA 2880299A1
Authority
CA
Canada
Prior art keywords
alkyl
heterocyclyl
heteroaryl
aryl
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2880299A
Other languages
English (en)
French (fr)
Inventor
Domenico Russo
Jorge Bruno Reis Wahnon
William MATON
Tibor Eszenyi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bial Portela and Cia SA
Original Assignee
Bial Portela and Cia SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bial Portela and Cia SA filed Critical Bial Portela and Cia SA
Publication of CA2880299A1 publication Critical patent/CA2880299A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/50Ketonic radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
CA2880299A 2012-07-27 2013-07-26 Process for the synthesis of substituted urea compounds Abandoned CA2880299A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261676554P 2012-07-27 2012-07-27
US61/676,554 2012-07-27
PCT/PT2013/000050 WO2014017938A2 (en) 2012-07-27 2013-07-26 Process for the synthesis of substituted urea compounds

Publications (1)

Publication Number Publication Date
CA2880299A1 true CA2880299A1 (en) 2014-01-30

Family

ID=49003969

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2880299A Abandoned CA2880299A1 (en) 2012-07-27 2013-07-26 Process for the synthesis of substituted urea compounds

Country Status (8)

Country Link
US (1) US20150197503A1 (OSRAM)
EP (1) EP2882712A2 (OSRAM)
JP (1) JP2015528013A (OSRAM)
CN (1) CN104662002A (OSRAM)
BR (1) BR112015001769A2 (OSRAM)
CA (1) CA2880299A1 (OSRAM)
RU (1) RU2015104103A (OSRAM)
WO (1) WO2014017938A2 (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201401198D0 (en) 2014-01-24 2014-03-12 Bial Portela & Ca Sa Process for the syntheis of substituted urea compounds
US10774064B2 (en) 2016-06-02 2020-09-15 Cadent Therapeutics, Inc. Potassium channel modulators
HRP20220079T1 (hr) 2017-01-23 2022-04-15 Cadent Therapeutics, Inc. Modulatori kalijevih kanala
AU2019227607C1 (en) 2018-02-27 2023-07-20 Incyte Corporation Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors
MA52940A (fr) 2018-05-18 2021-04-28 Incyte Corp Dérivés de pyrimidine fusionnés utilisés en tant qu'inhibiteurs de a2a/a2b
CA3105721A1 (en) 2018-07-05 2020-01-09 Incyte Corporation Fused pyrazine derivatives as a2a / a2b inhibitors
CA3116339A1 (en) 2018-10-22 2020-04-30 Cadent Therapeutics, Inc. Crystalline forms of potassium channel modulators
TWI829857B (zh) 2019-01-29 2024-01-21 美商英塞特公司 作為a2a / a2b抑制劑之吡唑并吡啶及三唑并吡啶

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1238971A (OSRAM) * 1968-03-02 1971-07-14
DE2458965C3 (de) * 1974-12-13 1979-10-11 Bayer Ag, 5090 Leverkusen 3-Amino-indazol-N-carbonsäure-Derivate, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel
EP0014810A3 (en) * 1979-01-18 1980-11-26 Fbc Limited Pesticidal pyrazoles, their production, compositions and uses, as well as intermediates and their preparation
GB8516573D0 (en) * 1985-07-01 1985-08-07 Janssen Pharmaceuticaa Nv Controlling weeds
JPH01203368A (ja) * 1988-02-10 1989-08-16 Mitsui Petrochem Ind Ltd チオイミダゾール誘導体
JPH01203366A (ja) * 1988-02-10 1989-08-16 Mitsui Petrochem Ind Ltd N−置換イミダゾール誘導体
FR2674855B1 (fr) * 1991-04-03 1994-01-14 Synthelabo Derives de piperidine, leur preparation et leur application en therapeutique.
CA2146755A1 (en) * 1992-10-28 1994-05-11 Kenji Takeda Novel 1,2-benzoisoxazole derivative or its salt and brain-protecting agent comprising the same
US20030203862A1 (en) * 1998-03-26 2003-10-30 Miraglia Loren J. Antisense modulation of MDM2 expression
EP1212416A2 (en) * 1999-08-31 2002-06-12 Ribozyme Pharmaceuticals, Inc. Nucleic acid based modulators of gene expression
EP1432690A2 (en) * 2001-04-16 2004-06-30 Tanabe Seiyaku Co., Ltd. Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence
US7329662B2 (en) * 2003-10-03 2008-02-12 Hoffmann-La Roche Inc. Pyrazolo-pyridine
DE102004005172A1 (de) * 2004-02-02 2005-08-18 Aventis Pharma Deutschland Gmbh Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
CN100424089C (zh) * 2006-01-18 2008-10-08 中国药科大学 一种制备大环内酯类半合成抗生素泰利霉素的方法
TWI469979B (zh) * 2008-12-24 2015-01-21 Bial Portela & Ca Sa 脂肪酸醯胺水解酶(faah)抑制劑、以及其藥學組成物與用途
BR112013001721A2 (pt) * 2010-07-29 2016-05-31 Bial Portela & Ca Sa processo de síntese de compostos de ureia substituída

Also Published As

Publication number Publication date
JP2015528013A (ja) 2015-09-24
RU2015104103A (ru) 2016-09-20
WO2014017938A2 (en) 2014-01-30
WO2014017938A3 (en) 2014-03-20
EP2882712A2 (en) 2015-06-17
CN104662002A (zh) 2015-05-27
US20150197503A1 (en) 2015-07-16
BR112015001769A2 (pt) 2017-08-22

Similar Documents

Publication Publication Date Title
CA2880299A1 (en) Process for the synthesis of substituted urea compounds
JP7168773B2 (ja) イソインドリン化合物、その調製方法、医薬組成物および使用
KR102426043B1 (ko) 액티빈 수용체 유사 키나아제의 저해제
CN111278816B (zh) 二氢喹啉酮
AU2018380426B2 (en) Processes for making modulators of cystic fibrosis transmembrane conductance regulator
EP2602260B1 (en) Process for preparing compound having hiv integrase inhibitory activity
CA2985542C (en) Triazole agonists of the apj receptor
CA2763960C (en) Bicyclic and tricyclic compounds as kat ii inhibitors
WO2017066014A1 (en) Bruton's tyrosine kinase inhibitors
KR20150021070A (ko) 피롤로[2,3-b]피리딘의 합성
RU2531274C2 (ru) Феноксиметильные гетероциклические соединения
TW201609696A (zh) 用於製備3-(3-氯-1h-吡唑-1-基)吡啶的方法(三)
HUE030794T2 (en) Synthesis Processes of Dihydro-Pyrido-Phthalazinone Derivatives
CN111683662B (zh) 取代嘧啶类化合物及其药物组合物和治疗方法
JP2022521536A (ja) イミダゾピリジニル化合物及び神経変性障害の処置のためのその使用
CA2806701A1 (en) Process for the synthesis of substituted urea compounds
CN120322430A (zh) Pcsk9抑制剂及其使用方法
JPWO2007126041A1 (ja) ベンゾイソオキサゾール化合物
CN106565674B (zh) 一种八氢环戊烷并[c]吡咯衍生物及其制备方法和在医药上的用途
JPWO2016143655A1 (ja) 1,2,4−オキサジアゾール誘導体の製造方法
US20180016270A1 (en) Diaza-benzofluoranthrene compounds
JP2008523154A (ja) 6−[(5s,9r)−9−(4−シアノフェニル)−3−(3,5−ジクロロフェニル)−1−メチル−2,4−ジオキソ−1,3,7−トリアザスピロ[4.4]ノン−7−イル]ニコチン酸の結晶形
US11078163B2 (en) Processes for the synthesis of substituted urea compounds
JP2004115450A (ja) 医薬組成物
JP2008523155A (ja) ピリジル置換スピロ−ヒダントイン化合物およびその使用

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20190726